North America Continuous Glucose Monitoring Market Overview

Continuous glucose monitoring (CGM) systems have revolutionized diabetes care across North America. With diabetes rates surging and patients demanding real-time monitoring, CGM devices have become a vital solution for better disease management. These devices allow individuals to track glucose levels continuously, enabling timely treatment decisions and helping reduce complications related to fluctuating blood sugar. Healthcare providers, patients, and caregivers increasingly rely on these systems to enhance quality of life. Technological advancements, rising awareness, and favorable reimbursement policies are supporting the steady expansion of the CGM market across the United States and Canada.

Expert Market Research Insights: North America Continuous Glucose Monitoring Market

A detailed report by Expert Market Research reveals that the North America continuous glucose monitoring market is positioned for remarkable advancement in the coming decade. The research highlights how growing investment in digital health, coupled with the rising diabetic population, is pushing companies to innovate continuously. Expert Market Research projects that emerging technologies and strong healthcare partnerships will play a pivotal role in making CGM systems more accessible and affordable for millions of patients across the United States and Canada.

North America Continuous Glucose Monitoring Market Size

The North America continuous glucose monitoring market reached an impressive value of USD 6.56 Billion in 2024, highlighting the increasing adoption of CGM devices in the region. This robust market size is a direct reflection of the growing diabetic population and strong focus on innovative product launches by leading players. With millions diagnosed with Type 1 and Type 2 diabetes, the demand for continuous and reliable glucose monitoring solutions is higher than ever. The large market size also points to the region’s strong healthcare infrastructure and proactive efforts by both private and public sectors to promote better diabetes management.

Market Trends Driving North America Continuous Glucose Monitoring

The North America continuous glucose monitoring market is witnessing transformative trends. One major trend is the surge in wearable technology integration, enabling easier glucose tracking through smartphones and smartwatches. The market is also seeing partnerships between tech companies and healthcare providers to deliver advanced digital health solutions. Miniaturization of sensors, improved accuracy, and longer sensor lifespans are reshaping user experience. Remote patient monitoring and telehealth integration have further fueled CGM adoption, especially post-pandemic. As people demand more personalized and real-time data, CGM systems continue to evolve with AI-driven insights and automated insulin delivery, setting new standards in diabetes care.

Market Opportunities and Challenges in North America

Despite remarkable growth, the North America continuous glucose monitoring market faces both opportunities and hurdles. Rising diabetes prevalence opens vast opportunities for manufacturers to expand their product portfolios and reach underserved segments. Government initiatives promoting diabetes awareness and digital health technologies further boost market potential. However, challenges such as high costs of devices and limited insurance coverage in certain areas remain barriers for widespread adoption. Some patients still prefer traditional glucose meters due to familiarity and affordability. Manufacturers must focus on cost-effective innovations and education programs to overcome these hurdles and capture untapped opportunities in the region.

For more information about this report visit

North America Continuous Glucose Monitoring Market Segmentation

• Breakup by Components:
  • Sensors
  • Transmitters
  • Receivers
• Breakup by Application:
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Others
• Breakup by Age Group:
  • Adult Population
  • Child Population
• Breakup by End User:
  • Hospitals & Clinics
  • Home Healthcare
  • Others
• Breakup by Region:
  • United States of America
  • Canada

North America Continuous Glucose Monitoring Market Growth

The North America continuous glucose monitoring market is experiencing strong growth due to advancements in healthcare technologies and increased awareness about diabetes management. Improved device accuracy and user-friendly features have led to higher adoption rates among patients and healthcare providers alike. The market’s expansion is supported by collaborations between medical device companies and insurance providers, making CGM systems more accessible. As diabetes cases continue to rise, especially among young adults, the demand for effective monitoring solutions intensifies. Companies are focusing on strategic investments in research and development to launch next-generation CGM systems, further accelerating the region’s market growth trajectory.

North America Continuous Glucose Monitoring Market Forecast

Looking ahead, the North America continuous glucose monitoring market is projected to grow at an impressive CAGR of 14.50% from 2025 to 2034, reaching an estimated value of USD 25.41 Billion by 2034. This significant forecast indicates robust demand for continuous monitoring solutions as more patients and healthcare providers recognize the benefits of real-time glucose tracking. Technological breakthroughs, coupled with favorable regulatory support, will drive adoption further. Increasing penetration in home healthcare and expanding telemedicine will also contribute to this rapid market expansion. Stakeholders can expect substantial returns as the market continues to mature and address existing healthcare gaps.

Competitor Analysis: Key Players in North America Continuous Glucose Monitoring

The competitive landscape is shaped by innovative leaders continuously enhancing their product portfolios to stay ahead.

• Abbott: Focuses on user-friendly CGM devices with high accuracy.
• Dexcom, Inc.: Renowned for cutting-edge wearable CGM technology.
• Medtronic PLC: Offers integrated CGM systems with insulin pumps.
• Senseonics, Inc.: Known for implantable long-term glucose monitoring.
• Byram Healthcare Centers, Inc.: Provides CGM supplies and patient support services.
• Hoffmann-La Roche Limited: Develops digital diabetes management solutions.

Find More Report:

CDMO Market trend

Power Assist Wheelchair Market size

Virus Filtration Market share